Publications (original articles or review articles) published in 2023 from OUS - The Lipid Clinic
3 publications found
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418 (in press)
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816
Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study
Acta Obstet Gynecol Scand (in press)
DOI 10.1111/aogs.14505, PubMed 36647289
[Not Available]
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.23.0023, PubMed 36718898